Patients should discuss risks carefully if they have: A history of pancreatitis Severe nausea, vomiting, or gastroparesis Gallbladder disease Severe dehydration risk Advanced kidney disease with frequent vomiting or poor oral intake A personal or family history of medullary thyroid cancer Multiple endocrine neoplasia syndrome type 2 Pregnancy, plans for pregnancy, or breastfeeding Also, if you have active lupus nephritis or unstable lupus, your rheumatologist and nephrologist should be involved before starting any new medicine that could affect hydration, nutrition, kidney function, or medication tolerance
In fact, when the FDA first approved a GLP-1 drug for weight loss in 2014, it was indicated for patients with BMI 30, or 27 with a weight-related comorbidity
As you age, changes in kidney function, liver metabolism, and body composition affect how medications are absorbed and how they work so your provider tailors the plan to you
NAD+ Infusion - neurological support and energy metabolism
Peters may not have the name recognition of his co-CEO partner Ted Sarandos, but the duo are on equal footing in running the streaming giant
Not all IV therapy is the same
